Pathogenesis of thoracic and abdominal aortic aneurysms

Annals of the New York Academy of Sciences

Volumn 1085, Issue , 2006, Pages 339-352

  Guo, Dong Chuan ^a   Papke, Christina L ^a   He, Rumin ^b   Milewicz, Dianna M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Abdominal aortic aneurysm; Apoptosis; Inflammation; Pathogenesis; Thoracic aortic aneurysm

Indexed keywords

ABDOMINAL AORTA ANEURYSM; AORTA ATHEROSCLEROSIS; BIOCHEMISTRY; CARDIOVASCULAR RISK; CONFERENCE PAPER; ELASTICITY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; PATHOGENESIS; PATHOLOGY; SMOOTH MUSCLE FIBER; THORACIC AORTA ANEURYSM; VASCULAR SMOOTH MUSCLE; ANIMAL; ATHEROSCLEROSIS; IMMUNOLOGY; INFLAMMATION; REVIEW;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; AORTIC ANEURYSM, THORACIC; ATHEROSCLEROSIS; HUMANS; INFLAMMATION;

EID: 34447633354     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1383.013     Document Type: Conference Paper

References (58)

1. KOCH, A.E., G.K. HAINES, R.J. RIZZO, et al. 1990. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am. J. Pathol. 137: 1199-1213.
2. JAFFER, F.A., C.J. O'DONNELL, M.G. LARSON, et al. 2002. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler. Thromb. Vasc. Biol. 22: 849-854.
3. SCOTT, R.A., K.A. VARDULAKI, N.M. WALKER, et al. 2001. The long-term benefits of a single scan for abdominal aortic aneurysm (AAA) at age 65. Eur. J. Vasc. Endovasc. Surg. 21: 535-540.
4. ROSS, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
5. CUSHING, S.D., J.A. BERLINER, A.J. VALENTE, et al. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA 87: 5134-5138.
6. YLA-HERTTUALA, S., B.A. LIPTON, M.E. ROSENFELD, et al. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88: 5252-5256.
7. BJORKERUD, S. & B. BJORKERUD. 1996. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am. J. Pathol. 149: 367-380.
8. HEGYI, L., J.N. SKEPPER, N.R. CARY & M.J. MITCHINSON. 1996. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J. Pathol. 180: 423-429.
9. BALL, R.Y., E.C. STOWERS, J.H. BURTON, et al. 1995. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis 114: 45-54.
10. GENG, Y.J. & P. LIBBY. 1995. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am. J. Pathol. 147: 251-266.
11. BENNETT, M.R. 1999. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc. Res. 41: 361-368.
12. TRION, A. & L.A. VAN DER. 2004. Vascular smooth muscle cells and calcification in atherosclerosis. Am. Heart J. 147: 808-814.
13. PROUDFOOT, D., J.N. SKEPPER, L. HEGYI, et al. 2000. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ. Res. 87: 1055-1062.
14. THOMPSON, R.W., S. LIAO & J.A. CURCI. 1997. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron. Artery Dis. 8: 623-631.
15. THOMPSON, R.W., P.J. GERAGHTY & J.K. LEE. 2002. Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr. Probl. Surg. 39: 110-230.
16. HENDERSON, E.L., Y.J. GENG, G.K. SUKHOVA, et al. 1999. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99: 96-104.
17. LIMET, R., B. NUSGENS, A. VERLOES & N. SAKALIHASAN. 1998. Pathogenesis of abdominal aortic aneurysm (AAA) formation. Acta. Chir. Belg. 98: 195-198.
18. GHORPADE, A. & B.T. BAXTER. 1996. Biochemistry and molecular regulation of matrix macromolecules in abdominal aortic aneurysms. Ann. N. Y. Acad. Sci. 800: 138-150.
19. SATTA, J., T. JUVONEN, K. HAUKIPURO, et al. 1995. Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J. Vasc. Surg. 22: 155-160.
20. SATTA, J., K. HAUKIPURO, M.I. KAIRALUOMA & T. JUVONEN. 1997. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. J. Vasc. Surg. 25: 909-915.
21. CAMPA, J.S., R.M. GREENHALGH & J.T. POWELL. 1987. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 65: 13-21.
22. SANGIORGI, G., R. D'AVERIO, A. MAURIELLO, et al. 2001. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 104: I288-I295.
23. SILENCE, J., F. LUPU, D. COLLEN & H.R. LIJNEN. 2001. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler. Thromb. Vasc. Biol. 21: 1440-1445.
24. THOMPSON, R.W. & W.C. PARKS. 1996. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann. N. Y. Acad. Sci. 800: 157-174.
25. LONGO, G.M., W. XIONG, T.C. GREINER, et al. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest 110: 625-632.
26. IKONOMIDIS, J.S., J.R. BARBOUR, Z. AMANI, et al. 2005. Effects of deletion of the matrix metalloproteinase 9 gene on development of murine thoracic aortic aneurysms. Circulation 112: I242-I248.
27. GITTENBERGER-DE GROOT, A.C., M.C. DERUITER, M. BERGWERFF & R.E. POELMANN. 1999. Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler. Thromb. Vasc. Biol. 19: 1589-1594.
28. BERGWERFF, M., M.E. VERBERNE, M.C. DERUITER, et al. 1998. Neural crest cell contribution to the developing circulatory system: implications for vascular morphology. Circ. Res. 82: 221-231.
29. TANG, P.C., M.A. COADY, C. LOVOULOS, et al. 2005. Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms. Circulation 112: 1098-1105.
30. LESAUSKAITE, V., P. TANGANELLI, C. SASSI, et al. 2001. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum. Pathol. 32: 1003-1011.
31. HE, R., D.C. GUO, A.L. ESTRERA, et al. 2006. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J. Thorac. Cardiovasc. Surg. 131: 671-678.
32. ZHU, L., R. VRANCKX, P.K. VAN KIEN, et al. 2006. Mutations inmyosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat. Genet. 38(3): 343-349.
33. SHIBAMURA, H., J.M. OLSON, C. VLIJMEN- VAN KEULEN, et al. 2004. Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation 109: 2103-2108.
34. GUO, D., S. HASHAM, S.Q. KUANG, et al. 2001. Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 103: 2461-2468.
35. HASHAM, S.N., M.C. WILLING, D.C. GUO, et al. 2003. Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation 107: 3184-3190.
36. VAUGHAN, C.J., M. CASEY, J.E.M. VEUGELERS, et al. 2001. Familial aortic aneurysms are genetically heterogeneous: identification of a novel genetic locus on chromosome 11q23. Circulation 103: 2469-2475.
37. LIBBY, P. 2002. Inflammation in atherosclerosis. Nature 420: 868-874.
38. SCHONBECK, U., G.K. SUKHOVA, N. GERDES & P. LIBBY. 2002. T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am. J. Pathol. 161: 499-506.
39. NUMANO, F. 2000. Vasa vasoritis, vasculitis and atherosclerosis. Int. J. Cardiol. 75(Suppl 1): S1-S8.
40. HERRON, G.S., E. UNEMORI, M. WONG, et al. 1991. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler. Thromb. 11: 1667-1677.
41. SHIMIZU, K., R.N. MITCHELL & P. LIBBY. 2006. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 26(5): 987-994.
42. CHAN, W.L., N. PEJNOVIC, T.V. LIEW & H. HAMILTON. 2005. Predominance of Th2 response in human abdominal aortic aneurysm: mistaken identity for IL-4-producing NK and NKT cells. Cell. Immunol. 233: 109-114.
43. HIROSE, H. & M.D. TILSON. 2001. Abdominal aortic aneurysm as an autoimmune disease. Ann. N. Y. Acad. Sci. 947: 416-418.
44. XIA, S., K. OZSVATH, H. HIROSE & M.D. TILSON. 1996. Partial amino acid sequence of a novel 40-kDa human aortic protein, with vitronectin-like, fibrinogen-like, and calcium binding domains: aortic aneurysm-associated protein-40 (AAAP-40) [human MAGP-3, proposed]. Biochem. Biophys. Res. Commun. 219: 36-39.
45. SUGIMOTO, T., M. SADA, T. MIYAMOTO & H. YAO. 2003. Genetic analysis on HLA loci in Japanese patients with abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 26: 215-218.
46. YEN, H.C., F.Y. LEE & L.Y. CHAU. 1997. Analysis of the T cell receptor V beta repertoire in human aortic aneurysms. Atherosclerosis 135: 29-36.
47. PLATSOUCAS, C.D., S. LU, I. NWANESHIUDU, et al. 2006. Abdominal aortic aneurysms (AAA) is a specific antigen-driven T-cell. Disease 125-127.
48. TANG, P.C., A.O. YAKIMOV, M.A. TEESDALE, et al. 2005. Transmural inflammation by interferon-gamma-producing T cells correlates with outward vascular remodeling and intimal expansion of ascending thoracic aortic aneurysms. FASEB J. 19: 1528-1530.
49. BLANCHARD, J.F. 1999. Epidemiology of abdominal aortic aneurysms. Epidemiol. Rev. 21: 207-221.
50. BENGTSSON, H., B. SONESSON & D. BERGQVIST. 1996. Incidence and prevalence of abdominal aortic aneurysms, estimated by necropsy studies and population screening by ultrasound. Ann. N. Y. Acad. Sci. 800: 1-24.
51. GRANGE, J.J., V. DAVIS & B.T. BAXTER. 1997. Pathogenesis of abdominal aortic aneurysm: an update and look toward the future. Cardiovasc. Surg. 5: 256-265.
52. DAVIS, V., R. PERSIDSKAIA, L. BACA-REGEN, et al. 1998. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 18: 1625-1633.
53. YOON, S., G. TROMP, S. VONGPUNSAWAD, et al. 1999. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem. Biophys. Res. Commun. 265: 563-568.
54. SHI, G.P., G.K. SUKHOVA, A. GRUBB, et al. 1999. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest 104: 1191-1197.
55. DAPUNT, O.E., J.D. GALLA, A.M. SADEGHI, et al. 1994. The natural history of thoracic aortic aneurysms. J. Thorac. Cardiovasc. Surg. 107: 1323-1332.
56. BICKERSTAFF, L.K., P.C. PAIROLERO, L.H. HOLLIER, et al. 1982. Thoracic aortic aneurysms: a population-based study. Surgery 92: 1103-1108.
57. ERDHEIM, J. 1930. Medionecrosis aortae idiopathica cystica Virchows. Arch. Path. Anat. 276: 187-192.
58. NATAATMADJA, M., M. WEST, J. WEST, et al. 2003. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 108(Suppl 1): II329-II334.